Quick Takeaways
- Denice Torres has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,706,692.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Denice Torres
- Location
- New Hope, PA
- Summary
- The estimated net worth of Denice Torres is at least $2,706,692 dollars as of 07 Jan 2026. Denice Torres is the Director of GLAUKOS Corp and owns shares of GLAUKOS Corp (GKOS) stock worth about $2.61M. Denice Torres is the Director of 2seventy bio, Inc. and owns shares of 2seventy bio, Inc. stock worth about $94.7K. Denice Torres is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. stock worth about $3.9K.
- Signature
- Diana Scherer, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Denice Torres and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: GLAUKOS Corp ($2,608,082).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Denice Torres
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GKOS | GLAUKOS Corp | Director | $2,608,082 | 02 Jan 2026 | ||
| TSVT | 2seventy bio, Inc. | Director | $94,713 | 13 May 2025 | ||
| BLUE | bluebird bio, Inc. | Director | $3,897 | 11 Nov 2021 | ||
| KRTX | Karuna Therapeutics, Inc. | Director | $0 | 18 Mar 2024 | ||
| CLDX | Celldex Therapeutics, Inc. | Director | 05 Jun 2025 | |||
| SURF | Surface Oncology, Inc. | Director | 08 Jun 2022 |
Insider Transactions Reported by Denice Torres:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.